Concepedia
Statistics
Publications
7
Citations
582
H-Index
Active since
2014
Affiliations
Gilead Sciences (United States)(Current)
The University of Texas MD Anderson Cancer Center
Yan Xin is an author at Gilead Sciences (United States) specializing in pharmacology, clinical pharmacology, and pharmacy.
Publications per year
2014–2024
Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study
John P. DeVincenzo, Richard J. Whitley, Richard L. Mackman et al. · New England Journal of Medicine · 2014 · 337 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +12
A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis
Vikas Gupta, Ruben A. Mesa, Michael W. Deininger et al. · Haematologica · 2016 · 94 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +13
Phase 1b Study of the Safety, Pharmacokinetics, and Disease-related Outcomes of the Matrix Metalloproteinase-9 Inhibitor Andecaliximab in Patients With Rheumatoid Arthritis
David Gossage, Blanka Cieslarová, Sophe Ap et al. · Clinical Therapeutics · 2017 · 50 citations
Medicine, Pharmacology, Pharmacotherapy +12
A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhibitor, in patients with polycythemia vera or essential thrombocythemia
Srđan Verstovšek, Stéphane Courby, Martin Grießhammer et al. · Leukemia Research · 2017 · 41 citations · Full text
Medicine, Hematology, Pharmacology +8
Influence of age and renal impairment on the steady state pharmacokinetics of filgotinib, a selective JAK1 inhibitor
Florence Namour, Liesbeth Fagard, Annegret Van der Aa et al. · British Journal of Clinical Pharmacology · 2018 · 31 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +17
1–5 of 7